Cargando…
AAV-mediated delivery of osteoblast/osteoclast-regulating miRNAs for osteoporosis therapy
Osteoporosis occurs due to a dysregulation in bone remodeling, a process requiring both bone-forming osteoblasts and bone-resorbing osteoclasts. Current leading osteoporosis therapies suppress osteoclast-mediated bone resorption but show limited therapeutic effects because osteoblast-mediated bone f...
Autores principales: | John, Aijaz Ahmad, Xie, Jun, Yang, Yeon-Suk, Kim, Jung-Min, Lin, Chujiao, Ma, Hong, Gao, Guangping, Shim, Jae-Hyuck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352805/ https://www.ncbi.nlm.nih.gov/pubmed/35950212 http://dx.doi.org/10.1016/j.omtn.2022.07.008 |
Ejemplares similares
-
Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
por: Yang, Yeon-Suk, et al.
Publicado: (2020) -
Osteoblast-Osteoclast Communication and Bone Homeostasis
por: Kim, Jung-Min, et al.
Publicado: (2020) -
AAV-Mediated Targeting of the Activin A-ACVR1(R206H) Signaling in Fibrodysplasia Ossificans Progressiva
por: Yang, Yeon-Suk, et al.
Publicado: (2023) -
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery
por: Yang, Yeon-Suk, et al.
Publicado: (2022) -
Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis
por: Yang, Yeon-Suk, et al.
Publicado: (2019)